Trvash P 37.5mg/325mg Tablet
Marketer
Zavik Drugs
Salt Composition
Tramadol (37.5mg) + Paracetamol (325mg)
Overview Trvash P 37.5mg/325mg Tablet
Combiflam P, a 37.5mg/325mg tablet, combines analgesics to effectively manage moderate to severe pain. Adhere strictly to your physician's prescribed dosage and regimen. Consumption may coincide with or precede meals; if stomach discomfort occurs, take with food. Consistent medication is crucial; discontinue only under your doctor's guidance. Potential side effects, including nausea, vomiting, dry mouth, dizziness, and constipation, are generally transient and mild. Report any rash or allergic reaction promptly. Pregnant women, those planning pregnancy, or breastfeeding mothers should consult their doctor before use.
Uses of Trvash P 37.5mg/325mg Tablet
Significant to intense pain
Major Benefits of Trvash P 37.5mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Trvash P 37.5mg/325mg Tablet whole; do not crush, chew, or break it. While it can be taken with or without food, consistency is key—take it at the same time each day.
Common Side effects of Trvash P 37.5mg/325mg Tablet:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Dryness in mouth
- Sleepiness
- Diarrhea
- Abdominal pain
- Dyspepsia
- Flatulence
- Headache
- Trembling
- Anxiety
- Sleep disorder
- Itching
How to use Trvash P 37.5mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not crush, chew, or break it. Trvash P 37.5mg/325mg Tablets can be ingested with or without food, although consistent timing is recommended.
How Trvash P 37.5mg/325mg Tablet works:
Each Trvash P 37.5mg/325mg tablet combines tramadol and paracetamol to effectively manage intense pain. Tramadol, an opioid analgesic, reduces pain perception by interrupting pain signals' journey to the brain. Paracetamol acts by inhibiting the release of specific chemicals responsible for pain sensation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Trvash P 37.5mg/325mg Tablet with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Trvash P 37.5mg/325mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your physician for advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Trvash P 37.5mg/325mg tablets are likely compatible. Available human data indicates minimal infant risk. However, seek immediate medical attention if your infant exhibits excessive drowsiness, feeding difficulties, respiratory distress, or hypotonia.
DrivingUNSAFE
Taking Trvash P 37.5mg/325mg tablets might impair your driving ability due to potential side effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Trvash P 37.5mg/325mg tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Trvash P 37.5mg/325mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Trvash P 37.5mg/325mg tablets are contraindicated for individuals experiencing severe or active liver disease.
What if you forget to take Trvash P 37.5mg/325mg Tablet :
Should you forget a Trvash P 37.5mg/325mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed amount.
Facts to Know About Trvash P 37.5mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Pain Relievers |
3,018 People bought this recently